Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Nascent Transcript and Single Cell Rnaseq Analysis Defines the Mechanism of Action of the LSD1 Inhibitor INCB059872 in Myeloid Leukemia

Gretchen Johnston, Haley E. Ramsey, PhDMSc, Kristy Stengel, PhD, Shilpa Sampathi, PhD, Pankaj Acharya, PhD, Maria Arrate, MSc, Matthew C. Stubbs, PhD, Timothy Burn, PhD, Scott Hiebert, PhD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 2509.

https://doi.org/10.1182/blood-2019-130458

Published: 2019

Journal Articles

A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies

Hamid Bolouri, PhD, Benjamin K. Johnson, PhD, Rhonda E. Ries, MA, Laura Pardo, Tiffany A. Hylkema, BS, Wanding Zhou, PhD, Jenny L. Smith, MSc, MD, Amanda R. Leonti, MS, Allison Kaeding, MD, Michael R. Loken, PhD, Jason E. Farrar, MD, Soheil Meshinchi, MD PhD, Timothy Junius Triche, Jr., PhD

Blood (2019) 134 (Supplement_1): 3768.

https://doi.org/10.1182/blood-2019-123487

Published: 2019

Journal Articles

Clinical Heterogeneity of AML Is Associated with Mutational Heterogeneity

Blood (2018) 132 (Supplement 1): 5240.

https://doi.org/10.1182/blood-2018-99-117287

Published: 2018

Journal Articles

Jarid2 Restricts Long-Term Repopulating Stem Cell Capacity in Multipotent Progenitors and Acts As Tumor Suppressor in Chronic Myeloid Neoplasms

Hamza Celik, PhD, Won Kyun Koh, MS, Elizabeth Leigh Ostrander, BS, Ashley C. Kramer, BS, William C Wilson, PhD, Greg Fishberger, BS, Cates Mallaney, MS, BS, Alok Kothari, MD, Grant Anthony Challen, PhD

Blood (2017) 130 (Supplement 1): 488.

https://doi.org/10.1182/blood.V130.Suppl_1.488.488

Published: 2017

Journal Articles

The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy

Fotini Kostopoulou, PhD, Nadia Bougacha, Clementine Gabillaud, Elise Chapiro, Simon Bouzy, Magali Le Garff-Tavernier, Pharm, PhD, Karim Maloum, Choquet Sylvain, Veronique Leblond, Jean Gabarre, Anne Lavaud, Veronique Morel, Damien Roos-Weil, Madalina Uzunov, Romain Guieze, MD PhD, Olivier Tournilhac, MD PhD, Santos Susin, Olivier Bernard, Florence Nguyen-Khac, MD PhD

Blood (2017) 130 (Supplement 1): 1729.

https://doi.org/10.1182/blood.V130.Suppl_1.1729.1729

Published: 2017

Journal Articles

The Genomic Landscape of Childhood T-Lineage Acute Lymphoblastic Leukemia

Blood (2015) 126 (23): 691.

https://doi.org/10.1182/blood.V126.23.691.691

Published: 2015

Journal Articles

Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

Jeffrey R. Sawyer, Erming Tian, Christoph J. Heuck, Donald J. Johann, Joshua Epstein, Charles M. Swanson, Janet L. Lukacs, Regina Lichti Binz, Marian Johnson, Gael Sammartino, Maurizio Zangari, Faith E. Davies, Frits van Rhee, Gareth J. Morgan, Bart Barlogie

Blood (2015) 125 (24): 3756–3759.

https://doi.org/10.1182/blood-2015-03-632075

Published: 2015

Includes: Supplemental data

Journal Articles

A Novel Enhancer Region 1.7Mb Downstream of the C-Myc Gene Drives Its Expression in Hematopoietic Stem and Progenitor Cells

Lisa von Paleske, MSc, Veli Vural Uslu, PhD, Massimo Petretich, MSc, Francois Spitz, PhD, Andreas Trumpp, PhD

Blood (2014) 124 (21): 766.

https://doi.org/10.1182/blood.V124.21.766.766

Published: 2014

Journal Articles

Inhibition of Splicing Factor SF3B1: Evaluating Effects on Iron Metabolism in K562 and CD34+ Cells

Simon Knight, PhD, Robert K. Bressin, Upamanyu Basu, Kazunori Koide, PhD, Andrew Dancis, MD

Blood (2014) 124 (21): 1348.

https://doi.org/10.1182/blood.V124.21.1348.1348

Published: 2014

Journal Articles

Posttranscriptional regulation of c-Myc expression in adult murine HSCs during homeostasis and interferon-α-induced stress response

Armin Ehninger, Tobias Boch, Hannah Uckelmann, Marieke A. Essers, Katja Müdder, Barry P. Sleckman, Andreas Trumpp

Blood (2014) 123 (25): 3909–3913.

https://doi.org/10.1182/blood-2013-10-531038

Published: 2014

Includes: Supplemental data

Journal Articles

N-Myc Is Overexpressed In Both Murine and Human Early T-Cell Precursor Leukemia and Is Sufficient To Initiate this Leukemia In Multipotent Primitive Arf -/- thymocytes

Louise M. Treanor, PhD, Sheng Zhou, PhD, Yu Fukuda, PhD, Nandakumar Satish, David Finkelstein, PhD, John D. Schuetz, PhD, Charles G. Mullighan, MBBS, MSc, MD, FRACP, FRCPA, Brian P. Sorrentino, MD

Blood (2013) 122 (21): 348.

https://doi.org/10.1182/blood.V122.21.348.348

Published: 2013

Journal Articles

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

Ilaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, Enrico Derenzini, MD, Anna Ferrari, Cristina Papayannidis, Claudia Venturi, Annalisa Lonetti, Viviana Guadagnuolo, Federica Cattina, Emanuela Ottaviani, Maria Chiara Abbenante, Domenico Russo, Michele Baccarani, MD, Pier Giuseppe Pelicci, Giovanni Martinelli, MD

Blood (2012) 120 (21): 1496.

https://doi.org/10.1182/blood.V120.21.1496.1496

Published: 2012

Journal Articles

Functional Enrichment Analysis by David in Transgenic MYCN Zebrafish Model

Li-Jing Shen, Fang-Yuan Chen, Lan-Fang Cao, Yong Zhang, Hua Zhong

Blood (2012) 120 (21): 5114.

https://doi.org/10.1182/blood.V120.21.5114.5114

Published: 2012

Journal Articles

The TLE1 Tumor Suppressor Regulates Myc Induced Leukemogenesis

David Sweetser, M.D., Ph.D., Selvi Ramasamy, PhD, Jessica S Blackburn, PhD, David M. Langenau, PhD

Blood (2011) 118 (21): 2473.

https://doi.org/10.1182/blood.V118.21.2473.2473

Published: 2011

Journal Articles

Microarray Analysis of CD34+CXCR4+ and CD34+CXCR4- Cells Reveals Two Distinct Hematopoietic Stem/Progenitor Populations

Robert E Donahue, VMD, Ping Jin, Yu Tian, Robyn S Allen, Aylin Bonifacino, David Stroncek, MD

Blood (2010) 116 (21): 4798.

https://doi.org/10.1182/blood.V116.21.4798.4798

Published: 2010

Journal Articles

Use of CALM-AF10 and NUP98-HOXD13 fusions to Identify Oncogenic Pathways That Collaborate with HOXA9 Overexpression

Rachel L Novak, PhD, David P Harper, MD, David L. Caudell, DVM, PhD, Sarah H Beachy, PhD, Yang Jo Chung, PhD, Linda Wolff, PhD, Peter Aplan, MD

Blood (2010) 116 (21): 2499.

https://doi.org/10.1182/blood.V116.21.2499.2499

Published: 2010

Journal Articles

Increasing C/Ebpα Expression Regulates the Transition of Hematopoietic Stem Cells During Development.

Min Ye, PhD, Hong Zhang, PhD, Pu Zhang, MD, Daniel G. Tenen, MD

Blood (2009) 114 (22): 1506.

https://doi.org/10.1182/blood.V114.22.1506.1506

Published: 2009

Journal Articles

Role of a Conserved Helicase Motif in the Transformation of Primary Human CD34+ Cells by the NUP98-DDX10 Oncogene.

Enas R Yassin, MD, Anmaar M Abdul-Nabi, MD, Akiko Takeda, PhD, Nabeel R. Yaseen, MD, PhD

Blood (2009) 114 (22): 2966.

https://doi.org/10.1182/blood.V114.22.2966.2966

Published: 2009

Journal Articles

NDRG1 Expression Is Inhibited in AML and Its Knockdown Attenuates Neutrophil Differentiation.

Mario P. Tschan, PhD, Deborah Shan, Judith Laedrach, Marianne Eyholzer, Elisabeth Oppliger Leibundgut, PhD, Gabriela Baerlocher, MD, Andreas Tobler, MD, Deborah Stroka, PhD, Martin F. Fey, MD

Blood (2008) 112 (11): 927.

https://doi.org/10.1182/blood.V112.11.927.927

Published: 2008

NARROW

Nascent Transcript and Single Cell Rnaseq Analysis Defines the Mechanism of Action of the LSD1 Inhibitor INCB059872 in Myeloid Leukemia

A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies

Clinical Heterogeneity of AML Is Associated with Mutational Heterogeneity

Jarid2 Restricts Long-Term Repopulating Stem Cell Capacity in Multipotent Progenitors and Acts As Tumor Suppressor in Chronic Myeloid Neoplasms

The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy

The Genomic Landscape of Childhood T-Lineage Acute Lymphoblastic Leukemia

Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

A Novel Enhancer Region 1.7Mb Downstream of the C-Myc Gene Drives Its Expression in Hematopoietic Stem and Progenitor Cells

Inhibition of Splicing Factor SF3B1: Evaluating Effects on Iron Metabolism in K562 and CD34+ Cells

Posttranscriptional regulation of c-Myc expression in adult murine HSCs during homeostasis and interferon-α-induced stress response

N-Myc Is Overexpressed In Both Murine and Human Early T-Cell Precursor Leukemia and Is Sufficient To Initiate this Leukemia In Multipotent Primitive Arf -/- thymocytes

In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL)

Functional Enrichment Analysis by David in Transgenic MYCN Zebrafish Model

The TLE1 Tumor Suppressor Regulates Myc Induced Leukemogenesis

SNP6 Array Better Defines Chronic Lymphocytic Leukemia (CLL) Prognostic Groups

Microarray Analysis of CD34+CXCR4+ and CD34+CXCR4- Cells Reveals Two Distinct Hematopoietic Stem/Progenitor Populations

Use of CALM-AF10 and NUP98-HOXD13 fusions to Identify Oncogenic Pathways That Collaborate with HOXA9 Overexpression

Increasing C/Ebpα Expression Regulates the Transition of Hematopoietic Stem Cells During Development.

Role of a Conserved Helicase Motif in the Transformation of Primary Human CD34+ Cells by the NUP98-DDX10 Oncogene.

NDRG1 Expression Is Inhibited in AML and Its Knockdown Attenuates Neutrophil Differentiation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only